HealthEquity (HQY) – Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of HealthEquity (NASDAQ: HQY) recently:

• 12/8/2025 – HealthEquity is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $118.00 price target on the stock.
• 12/5/2025 – HealthEquity had its “buy” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They now have a $120.00 price target on the stock.
• 12/4/2025 – HealthEquity had its “market perform” rating reaffirmed by analysts at BMO Capital Markets.
• 12/4/2025 – HealthEquity was given a new $122.00 price target on by analysts at JMP Securities.
• 12/4/2025 – HealthEquity had its “outperform” rating reaffirmed by analysts at Citigroup Inc..
• 12/4/2025 – HealthEquity had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $125.00 price target on the stock.
• 12/4/2025 – HealthEquity had its price target raised by analysts at JPMorgan Chase & Co. from $126.00 to $129.00. They now have an “overweight” rating on the stock.
• 12/4/2025 – HealthEquity had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $130.00 price target on the stock.
• 12/4/2025 – HealthEquity had its price target raised by analysts at Citizens Jmp from $117.00 to $122.00. They now have a “market outperform” rating on the stock.
• 11/15/2025 – HealthEquity was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/13/2025 – HealthEquity is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $100.00 price target on the stock.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total value of $156,840.00. Following the completion of the transaction, the executive vice president directly owned 75,479 shares of the company’s stock, valued at $7,892,084.24. This trade represents a 1.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 10,781 shares of company stock worth $1,016,707. 1.50% of the stock is owned by insiders.

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.